Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Moulin, Dwight E.
1989.
Pain in Multiple Sclerosis.
Neurologic Clinics,
Vol. 7,
Issue. 2,
p.
321.
Pert, Vivien F
1991.
Tens for Pain in Multiple Sclerosis.
Physiotherapy,
Vol. 77,
Issue. 3,
p.
227.
Brin, Mitchell F.
Blitzer, Andrew
Stewart, Celia
Pine, Zachary
Borg-Stein, Joanne
Miller, James
Viswanath, Nagalapura S.
and
Rosenfield, David B.
1993.
Botulinum and Tetanus Neurotoxins.
p.
559.
Guiloff, R. J.
1995.
Motor Neuron Disease.
p.
345.
Stolp-Smith, Kathryn A.
Carter, Jonathan L.
Rohe, Daniel E.
and
Knowland, Daniel P.
1997.
Management of Impairment, Disability, and Handicap Due to Multiple Sclerosis.
Mayo Clinic Proceedings,
Vol. 72,
Issue. 12,
p.
1184.
Hummelsheim, Horst
1998.
Neurologische Rehabilitation.
p.
149.
Lawson, Kim
1998.
Tizanidine.
Physiotherapy,
Vol. 84,
Issue. 9,
p.
418.
Moulin, Dwight E.
1998.
PAIN IN CENTRAL AND PERIPHERAL DEMYELINATING DISORDERS.
Neurologic Clinics,
Vol. 16,
Issue. 4,
p.
889.
Barbeau, Hugues
Ladouceur, Michel
Norman, Kathleen E.
Pépin, André
and
Leroux, Alain
1999.
Walking after spinal cord injury: Evaluation, treatment, and functional recovery.
Archives of Physical Medicine and Rehabilitation,
Vol. 80,
Issue. 2,
p.
225.
Smith, Howard S.
and
Barton, Amy E.
2000.
Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population.
American Journal of Hospice and Palliative Medicine®,
Vol. 17,
Issue. 1,
p.
50.
Barnes, Michael
2000.
Zanaflex (tizanidine hydrochloride) in spasticity management.
British Journal of Therapy and Rehabilitation,
Vol. 7,
Issue. 4,
p.
192.
Gelber, David A.
Good, David C.
Dromerick, Alexander
Sergay, Stephen
and
Richardson, Melissa
2001.
Open-Label Dose-Titration Safety and Efficacy Study of Tizanidine Hydrochloride in the Treatment of Spasticity Associated With Chronic Stroke.
Stroke,
Vol. 32,
Issue. 8,
p.
1841.
Hinderer, Steven R.
and
Dixon, Kelly
2001.
Physiologic and Clinical Monitoring of Spastic Hypertonia.
Physical Medicine and Rehabilitation Clinics of North America,
Vol. 12,
Issue. 4,
p.
733.
Francisco, Gerard E.
Kothari, Sunil
and
Huls, Christine
2001.
GABA Agonists and Gabapentin for Spastic Hypertonia.
Physical Medicine and Rehabilitation Clinics of North America,
Vol. 12,
Issue. 4,
p.
875.
Burchiel, Kim J.
and
K. Hsu, Frank P.
2001.
Pain and Spasticity After Spinal Cord Injury.
Spine,
Vol. 26,
Issue. Supplement,
p.
S146.
Dawson, David M.
2001.
Evidence basis for treatment of spasticity.
Current Neurology and Neuroscience Reports,
Vol. 1,
Issue. 6,
p.
501.
Elovic, Elie
2001.
Principles of Pharmaceutical Management of Spastic Hypertonia.
Physical Medicine and Rehabilitation Clinics of North America,
Vol. 12,
Issue. 4,
p.
793.
Gelber, David A.
2002.
Clinical Evaluation and Management of Spasticity.
p.
125.
Jeffery, Douglas R.
2002.
Clinical Evaluation and Management of Spasticity.
p.
287.
Bastings, Eric P.
and
Malapira, Amelito
2002.
Clinical Evaluation and Management of Spasticity.
p.
103.